The depletion of CUL5/SOCS3 stabilized integrin ß1 and promoted metastasis through focal adhesion kinase/SRC signaling pathway, which predicts the potential benefit for CUL5-deficient SCLC patients from receiving SRC inhibitor treatment [57]. The gene discussed is SOCS3; the disease is small cell lung carcinoma.